Source | ||
---|---|---|
Model characteristics | ||
Number of patients | 89,030 | |
Number of replications | 1 | |
Cutoff for mild AD | 4.5 | [31] |
Cutoff for moderate AD | 9.5 | [31] |
Population characteristics | ||
Population projections by age group (2020–2035) | INE | |
Incidence rates | Literature | [26] |
Age of the caregiver (mean) | 55.2 | [15] |
Baseline CDR-SB score (mean) | 1.76 | [15] |
Baseline MMSE score (mean) | 26.9 | [15] |
Annual costs (mean) | [32] payer | |
Treatment with Souvenaid (per year) | €1200 | Patient |
Diagnosis | €284 | Health service |
Direct healthcare for mild AD | €3388 | Health service |
Direct social care for mild AD | €13,927 | F&SS |
Indirect for mild AD | €647 | |
Total for mild AD | €17,962 | |
Direct healthcare for moderate/severe AD | €4659 | Health service |
Direct social care for moderate/severe AD | €34,893 | F&SS |
Indirect for moderate/severe AD | €820 | |
Total for moderate/severe AD | €40,372 |